Literature DB >> 7842194

Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease.

P Jakobsson1, L Jorfeldt, J Henriksson.   

Abstract

Eighteen patients with severe COPD and seven healthy control subjects 64.0 +/- 2.2 and 66.8 +/- 1.4 yr of age, respectively (mean +/- SEM), were investigated. Arterial blood gas analysis, dynamic lung volumes, and muscle biopsy specimens from the quadriceps femoris muscle were performed. The muscle biopsies were analyzed for citrate synthase (CS), succinic acid dehydrogenase (SDH), 3-hydroxyacyl-CoA dehydrogenase (HAD), phosphofructokinase (PFK), and lactate dehydrogenase (LDH) activities and related to protein content. The PFK activity was higher in the COPD group than in the control group (+34%, p < 0.05). CS showed a group difference in the opposite direction (-29%, p < 0.05). LDH activity followed PFK and tended to be higher in the patient group (+27%, NS), whereas SDH (-31%, NS) and HAD (-28%, NS) mirrored the CS results. Muscle protein concentration tended to be lower in the COPD group (-14%, NS). There were no significant changes in enzyme activity after 7 mo of long-term oxygen therapy (n = 6). These results indicate adaptation in the form of augmented glycolysis (PFK), and decreased aerobic metabolism (CS) in the quadriceps femoris muscle in patients with advanced COPD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7842194     DOI: 10.1164/ajrccm.151.2.7842194

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  33 in total

1.  Skeletal muscle endurance and muscle metabolism in patients with chronic heart failure.

Authors:  Patrice Brassard; Francois Maltais; Martin Noel; Jean-François Doyon; Pierre LeBlanc; Joakim Allaire; Clermont Simard; Marie-Hélène Leblanc; Paul Poirier; Jean Jobin
Journal:  Can J Cardiol       Date:  2006-04       Impact factor: 5.223

Review 2.  Respiratory muscle fibres: specialisation and plasticity.

Authors:  B Polla; G D'Antona; R Bottinelli; C Reggiani
Journal:  Thorax       Date:  2004-09       Impact factor: 9.139

3.  Glucose and pyruvate metabolism in severe chronic obstructive pulmonary disease.

Authors:  Christina C Kao; Jean W-C Hsu; Venkata Bandi; Nicola A Hanania; Farrah Kheradmand; Farook Jahoor
Journal:  J Appl Physiol (1985)       Date:  2011-10-20

4.  Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD.

Authors:  F Maltais; P LeBlanc; F Whittom; C Simard; K Marquis; M Bélanger; M J Breton; J Jobin
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

Review 5.  Mitochondria in lung disease.

Authors:  Suzanne M Cloonan; Augustine M K Choi
Journal:  J Clin Invest       Date:  2016-03-01       Impact factor: 14.808

Review 6.  Clinical management of chronic obstructive pulmonary disease patients with muscle dysfunction.

Authors:  Joaquim Gea; Carme Casadevall; Sergi Pascual; Mauricio Orozco-Levi; Esther Barreiro
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

Review 7.  Effects of aging and comorbidities on nutritional status and muscle dysfunction in patients with COPD.

Authors:  Bruno-Pierre Dubé; Pierantonio Laveneziana
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

8.  Quadriceps muscle strength in scoliosis.

Authors:  E B Swallow; E Barreiro; H Gosker; S A Sathyapala; F Sanchez; N S Hopkinson; J Moxham; A Schols; J Gea; M I Polkey
Journal:  Eur Respir J       Date:  2009-05-14       Impact factor: 16.671

9.  Cellular assessment of muscle in COPD: case studies of two males.

Authors:  Howard J Green; Eric Bombardier; Margaret E Burnett; Christine L D'Arsigny; Sobia Iqbal; Katherine A Webb; Jing Ouyang; Denis E O'Donnell
Journal:  Int J Gen Med       Date:  2009-12-29

Review 10.  Factors contributing to muscle wasting and dysfunction in COPD patients.

Authors:  Rob C I Wüst; Hans Degens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.